MedPath

Clinical, Biological and NMR Outcome Measures Study for Hereditary Inclusion Body Myopathy Due to Mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene (GNE)

Not Applicable
Completed
Conditions
HIBM
Registration Number
NCT02196909
Lead Sponsor
Institut de Myologie, France
Brief Summary

The objective of the study is to identify the best clinical and biological outcome measures for further therapeutics approaches.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Must be at least 18 years of age.
  • Must be willing and able to provide consent.
  • Must have a genetic diagnosis of HIBM, GNE myopathy, Quadriceps Sparing Myopathy (QSM), Inclusion Body Myopathy Type 2, distal myopathy with rimmed vacuoles (DMRV), or Nonaka disease.
  • Must be willing and able to comply with all study requirements.
  • Affiliated to or a beneficiary of a social security category
  • Must take part in the HIBM-PMP UX001-CL401 study
Exclusion Criteria
  • Received ManNAc therapy or other similar substance
  • Any unrelated, comorbid disease or condition that, in the view of the investigator, would interfere with study participation or would affect safety.
  • Patients with specific contraindication to MRI (i.e. metallic foreign body, claustrophobia...) will be allowed to participate, but MRI will not be performed.
  • Pregnant women.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Measure of changes in motor function and muscle strength assessment between 2 time pointsbaseline, 1 year, 2 years, 3 years
Measure of changes in NMR upper and lower limbs assessment between 2 timepoints(not for controls)baseline, 1 year, 2 years, 3 years
24h urine and serum collection, measures at different time pointsbaseline, 1 year, 2 years, 3 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institute of Myology

🇫🇷

Paris, France

Institute of Myology
🇫🇷Paris, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.